You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire

Article metrics

Article menu

Download PDFPDF

Research Article
Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire

 

Online download statistics by month:

Online download statistics by month: December 2019 to July 2025

AbstractFullPdf
Dec 2019330
Jan 2020660
Feb 202020203
Mar 202024244
Apr 202021210
May 202020207
Jun 202017173
Jul 202018182
Aug 2020442
Sep 202025255
Oct 202023234
Nov 202016172
Dec 202016162
Jan 202127278
Feb 202116168
Mar 202115153
Apr 202116164
May 202121217
Jun 202117172
Jul 202123236
Aug 202117174
Sep 2021282812
Oct 202122226
Nov 202120207
Dec 2021202010
Jan 202226279
Feb 202228285
Mar 202220208
Apr 202218199
May 2022323417
Jun 2022353618
Jul 202234357
Aug 202244456
Sep 2022494916
Oct 2022353510
Nov 2022206516
Dec 202213135
Jan 2023393917
Feb 2023464718
Mar 202324249
Apr 2023242413
May 2023252519
Jun 202315151
Jul 202311117
Aug 2023774
Sep 202312123
Oct 202398986
Nov 2023992
Dec 2023414111
Jan 202422231
Feb 2024303014
Mar 2024212111
Apr 202426266
May 2024282812
Jun 2024202012
Jul 2024353614
Aug 2024252512
Sep 2024191912
Oct 2024212114
Nov 202419232
Dec 2024555610
Jan 2025171725
Feb 2025242416
Mar 202523235
Apr 2025545419
May 2025242716
Jun 2025272716
Jul 2025110
Total16511715564